Functional Magnetic Resonance Imaging in Alzheimer' Disease Drug Development.

Holiga, Stefan; Abdulkadir, Ahmed; Klöppel, Stefan; Dukart, Juergen (2018). Functional Magnetic Resonance Imaging in Alzheimer' Disease Drug Development. In: Biomarkers for Alzheimer’s Disease Drug Development. Methods in Molecular Biology: Vol. 1750 (pp. 159-163). Springer 10.1007/978-1-4939-7704-8_10

[img] Text
Current biomarkers in drug development_bookChapter_v2.pdf - Accepted Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (287kB) | Request a copy
[img] Text
978-1-4939-7704-8_10.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (256kB) | Request a copy

While now commonly applied for studying human brain function the value of functional magnetic resonance imaging in drug development has only recently been recognized. Here we describe the different functional magnetic resonance imaging techniques applied in Alzheimer's disease drug development with their applications, implementation guidelines, and potential pitfalls.

Item Type:

Book Section (Book Chapter)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Geriatric Psychiatry and Psychotherapy

UniBE Contributor:

Abdulkadir, Ahmed and Klöppel, Stefan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1940-6029

ISBN:

978-1-4939-7703-1

Series:

Methods in Molecular Biology

Publisher:

Springer

Language:

English

Submitter:

Katharina Klink

Date Deposited:

23 Apr 2018 14:54

Last Modified:

23 Apr 2018 14:54

Publisher DOI:

10.1007/978-1-4939-7704-8_10

PubMed ID:

29512071

Uncontrolled Keywords:

Alzheimer’s disease Biomarker Dementia Prevention Treatment fMRI

BORIS DOI:

10.7892/boris.112608

URI:

https://boris.unibe.ch/id/eprint/112608

Actions (login required)

Edit item Edit item
Provide Feedback